Basophil Sensitivity Increases Briefly during the Up Dosing Phase of Subcutaneous Immunotherapy.

被引：0
|
作者：
Hoffmann, H. J. [1 ]
Hansen, S. [1 ]
Hansen, M. B. [1 ]
Bibby, B. M. [2 ]
Dahl, R. [1 ]
机构：
[1] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark
[2] Aarhus Univ, Aarhus, Denmark
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2009年 / 179卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2867
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Randomised, controlled, multicenter, phase IV study with house dust Mites subcutaneous immunotherapy. Twelve months immunological changes in the ALUMITES study
    Sanchez, J.
    Vidal, C.
    Hernandez, D.
    Malek, T.
    Pelaez, A.
    Garcia, M. A.
    Valero, A.
    [J]. ALLERGY, 2014, 69 : 406 - 406
  • [22] Adherence to Allergen Subcutaneous Immunotherapy is Increased by a Shortened Build-Up Phase: A Retrospective Study
    Caruso, Cristiano
    Brame, Barbara
    Bagnasco, Diego
    Cocconcelli, Alessia
    Ortolani, Valeria
    Pravettoni, Valerio
    Scarpa, Sergio
    Zisa, Giuliana
    Passalacqua, Giovanni
    Colantuono, Stefania
    [J]. BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [23] Randomised, controlled, multicenter, phase IV study with house dust mites subcutaneous immunotherapy. Twelve months quality of life results in the ALUMITES study
    Sanchez, J.
    Vidal, C.
    Hernandez, D.
    Malek, T.
    Pelaez, A.
    Garcia, M. A.
    Valero, A.
    [J]. ALLERGY, 2014, 69 : 404 - 404
  • [24] Randomised, controlled, multicenter, phase IV study with house dust Mites subcutaneous immunotherapy. Twelve months symptoms and medication scores results in the ALUMITES study
    Sanchez, J.
    Vidal, C.
    Hernandez, D.
    Malek, T.
    Pelaez, A.
    Garcia, M. A.
    Valero, A.
    [J]. ALLERGY, 2014, 69 : 406 - 407
  • [25] The LC50 of the basophil -activation test increases during venom immunotherapy, and correlates to changes in venom-specific IgE levels
    de Groot, C.
    Nawijn, M.
    van der Heide, S.
    Elberink, Oude H.
    [J]. ALLERGY, 2012, 67 : 599 - 599
  • [26] Intra-seasonal short-time up-dosing with SQ-standardised subcutaneous immunotherapy in patients with intermittent allergic rhinoconjunctivitis is well tolerated during routine application
    Reiber, R.
    Wolf, H.
    Schnitker, J.
    Wuestenberg, E.
    [J]. ALLERGY, 2011, 66 : 302 - 302
  • [27] Safety and tolerability during build-up phase of a rush venom immunotherapy
    Bernkopf, Kathleen
    Roensch, Henriette
    Spornraft-Ragaller, Petra
    Neumeister, Volker
    Bauer, Andrea
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 116 (04) : 360 - 365
  • [28] IgG antibodies produced during subcutaneous allergen immunotherapy mediate inhibition of basophil activation via a mechanism involving both FcγRIIA and FcγRIIB
    Cady, Carol T.
    Powell, Maree S.
    Harbeck, Ronald J.
    Giclas, Patricia C.
    Murphy, James R.
    Katial, Rohit K.
    Weber, Richard W.
    Hogarth, P. Mark
    Johnson, Syd
    Bonvini, Ezio
    Koenig, Scott
    Cambier, John C.
    [J]. IMMUNOLOGY LETTERS, 2010, 130 (1-2) : 57 - 65
  • [29] Switching from subcutaneous to sublingual immunotherapy during the maintenance phase in patients with house dust mite allergy
    Kiatiwat, Ploykarn
    Sangasapaviliya, Atik
    Pradubpongsa, Panitan
    Sangkanjanavanich, Sasipa
    Chiewchalermsri, Chirawat
    Jacquet, Alain
    Jaisupa, Nattapol
    Jindarat, Sarawut
    Boonpiyathad, Tadech
    Mitthamsiri, Wat
    [J]. ALLERGY, 2023, 78 (07) : 2019 - 2021
  • [30] Early efficacy results in the Alumites study: a randomized, controlled, multicenter, phase IV study with house dust mites subcutaneous immunotherapy. Two months symptoms and medication scores
    Sanchez-Lopez, J.
    Vidal, C.
    Hernandez, D.
    Pelaez, A.
    Azpeitia, A.
    Valero, A.
    [J]. ALLERGY, 2015, 70 : 456 - 457
12345